跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERETIDE ACCUHALER 500/50 powder for inhalation blister - TGA Drug Approval Details
Approvals
/
TGA
/
SERETIDE ACCUHALER 500/50 powder for inhalation blister
Approved
STANDARD
SERETIDE ACCUHALER 500/50 powder for inhalation blister
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
defd125fa2b28197
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
defd125fa2b28197
Product Name
SERETIDE ACCUHALER 500/50 powder for inhalation blister
Artg Id
70174
Artg Name
SERETIDE ACCUHALER 500/50 powder for inhalation blister pack
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2000-02-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9475d49eb52862e433fc805074f41ccc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/257671c3574403644ffe3e759fdda084.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
defd125fa2b28197
Type
Standard
Back to TGA Approvals
